Bristol Myers Squibb Equity Dashboard

<div class='circular--portrait' style='background:#689CFD;color: #ffffff;font-size:4em;padding-top: 25px;;'>BM</div>
BMY -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

The Bristol Myers Squibb Equities Center is a collection of modules for Bristol Myers equity research and analysis. Using equity center you examine different market driven as well as company specific characteristics using powerful technical, fundamental, predictive and other Bristol Myers Squibb specific modules. Please select from the options below.
This is a quick snapshot of Bristol Myers Squibb research areas. You can expand your research by examining different market driven as well as company specific characteristics using powerful cross-assets modules such as watchlist analyzer, correlation inspector, opportunity browser, portfolio optimizer and and many other powerfull tools.
Quote & Profile

Quote & Profile

Bristol Myers profile, quote, and daily performance
Earnings Estimate

Earnings Estimate

Historical and projected earnings estimates for Bristol Myers Squibb
Updated
Fundamental Analysis

Fundamental Analysis

Fundamentals and financial ratios for Bristol Myers Squibb
Event Calendar

Event Calendar

Calendar of corporate events and headlines for Bristol Myers Squibb
Updated
Technical Analysis

Technical Analysis

Basic technical indicators and analysis for Bristol Myers
Momentum Indicators

Momentum Indicators

View over 20 different momentum indicators for Bristol Myers Squibb
Updated
Alpha Analysis

Alpha Analysis

Instant market alpha and beta exploration for Bristol Myers
Chance of Bankruptcy

Chance of Bankruptcy

Bristol Myers chance of financial distress in the next 2 years
Pattern Recognition

Pattern Recognition

View over 30 different Bristol Myers Squibb historical pattern-recognition indicators
Current Valuation

Current Valuation

Bristol Myers valuation after adjusting for liquid asset and debt
News and Headlines

News and Headlines

Bristol Myers current and past headlines and price impact
Bollinger Bands

Bollinger Bands

Analyze Bristol Myers Bollinger Bands indicator to determine target price movement boundaries
Historical Volatility

Historical Volatility

Bristol Myers Squibb volatility and risk analysis compared to market
Updated
Correlation With Market

Correlation With Market

Bristol Myers Squibb correlation with market
Backtesting

Backtesting

Backtesting to check gain and loss over specified period
Compare to peers

Compare to peers

Bristol Myers Squibb in the context of related companies
Management

Management

Bristol Myers Squibb leadership and management evaluation
Performance

Performance

Risk adjusted expected returns and performance analysis
Risk-adjusted Recommendation

Risk-adjusted Recommendation

Personalized buy or sell advice on Bristol Myers Squibb
Power Widgets

Power Widgets

Macroaxis widgets syndication for Bristol Myers Squibb
Price Prediction

Price Prediction

Basic Bristol Myers price forecast based on headlines and hype
Updated
Analyst Recommendations

Analyst Recommendations

Analyst recommendations and target price estimates for Bristol Myers Squibb
Piotroski F Score

Piotroski F Score

Piotroski F Score is based on binary analysis strategy of Bristol Myers Squibb
Fundamental History

Fundamental History

Bristol Myers Squibb history of fundamentals from various financial
Revenue

Revenue

Relative Bristol Myers Squibb revenue analysis
Updated
Net Income Analysis

Net Income Analysis

Bristol Myers Squibb income analysis for the latest period
Financial Leverage

Financial Leverage

Effects of financial leverage on Bristol Myers Squibb operations
Balance Of Power

Balance Of Power

Daily balance of power indicator of Bristol Myers
Semi-Deviation

Semi-Deviation

Current Semi-Deviation of Bristol Myers Squibb
Price History

Price History

Bristol Myers daily price history and news impact
Updated
Pair Correlation

Pair Correlation

Correlation between Bristol Myers and Astrazeneca PLC
BMY vs. GSK

BMY vs. GSK

Fundamentals comparison between Bristol Myers and GlaxoSmithKline PLC
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page